Otomicol contains miconazole nitrate, prednisolone acetate and polymyxin B.
The product targets a range of pathogens including miconazole and polymyxin B-sensitive, Malassezia and Pseudomonas spp.
Renzo Di Florio, technical vet at Krka UK, said: “With its multifactorial aetiology, ear disease is often challenging to manage, causing frustration for owners and significant discomfort for pets.
"Otomicol is a cost-effective solution that veterinary surgeons can add to their treatment toolbox for cases where bacterial and fungal infection are important factors.”
Otomicol ear drops and cutaneous suspension are available in a 15ml bottle with an extended shelf life of six months after opening.
Otomicol is available from veterinary wholesalers.
https://www.krka.co.uk
Reference
Vétoquinol has released the results of a survey of 1000 dog owners, which looked into their attitudes towards long-term medication for their pet1.
Owners were asked to rate how important various factors were to them when it came to giving medicine long term to their dog. They were also asked to consider what they felt was most important to their vet when it came to choosing a medicine.
Vétoquinol says the fact that dog owners rate the effectiveness of a medication much more highly than the cost means there is very little reason to compromise on treatment based on a presumption of what clients will want to pay. These findings are also largely very positive in that they suggest that dog owners believe that in many areas vets are making decisions based on criteria that are important to owners. The area where there is the greatest mismatch is over the risk of side effects of medication.
Pet owners think that vets may take the risk of side effects from long-term medications less seriously than the owners themselves might prefer. It suggests that the risk of potential harm, no matter how small the risk of actual harm is, may be more unacceptable to the dog owner than vets and nurses might otherwise presume. When prescribing long-term medication there is a need to talk about the risks associated with medication more openly and to take the client's attitudes to risk into consideration.
1. A survey of 1048 dog owners, carried out by petbuzz, on behalf of Vétoquinol, March 2011
The British Veterinary Association's Animal Welfare Foundation has produced an online advice leaflet to guide veterinary surgeons through the possible scenarios in the consulting room.
'The practical and legal approach to the docked puppy' leaflet answers questions like:
Introducing the leaflet BVA AWF Chair Tiffany Hemming said: "With such complex and varying laws on tail docking of dogs this leaflet provides clear guidance for vets on how to handle the first consultation with a docked puppy.
"The leaflet includes an easy to follow flow-chart and aims to help vets tackle the subject without alienating their clients."
You can view the leaflet here.
A survey of almost 1400 ferret owners carried out by the Ferret Education & Research Trust (FERT) and pet food manufacturers James Wellbeloved has revealed that 40% of the UK's ferret owners never take their animals to a vet, with a further 9% saying they visit the vet only occasionally.
In addition, 76% of ferret owners have not had them microchipped, 64% have not bothered with vaccination against distemper and 74% with vaccination against rabies.
Almost three quarters are registered with a vet for emergency treatment, but 26% are not registered at all.
Ian Kearns from FERT said: "This is quite an alarming picture in terms of ferret welfare; however it offers a clear opportunity for vets to address the issue. Ferrets are growing fast in popularity as pets, and it may be that as their role changes they will visit the vet more - but we believe that vets can seize an opportunity by promoting ferret welfare via the waiting room."
The survey also showed that 65% are fed on mixed biscuits and meat. James Wellbeloved Ferret Complete Food was the clear leader, outselling its' nearest rival by almost five times to one. Over half are kept outdoors, and there is a wide choice of bedding material including commercially made washable fabric, straw and paper.
Peter Lancaster, James Wellbeloved marketing director said: "Ferrets are growing in popularity, but because owners sometimes don't do enough research a worrying number are ending up in rescues. Veterinary practices are of course very well-placed to focus on ferret welfare, and we'd urge any vets and vet nurses who want to know more to get in touch with the team at FERT."
10 THINGS YOU NEVER KNEW ABOUT FERRETS...
The RCVS has announced that it is carrying out an audit of continuing professional development (CPD) for vets in order to monitor compliance and gauge what type of activities they are engaging in.
Under the RCVS Code of Professional Conduct, introduced in 2012, veterinary surgeons are expected to undertake 105 hours of CPD over a rolling three-year period in order to demonstrate that they are maintaining and advancing their knowledge and skills.
Nearly 5,000 vets - made up of three cohorts - have been asked to share their CPD records. The first cohort comprises 4,425 UK-practising vets who registered before 1 April 2012 but who did not confirm their CPD compliance upon renewing their registration this year. The second cohort comprises a random sample of 400 vets who did confirm their compliance upon renewing their registration this year. The third cohort comprises 84 vets who graduated before 2012 but have not yet completed their post-graduation Professional Development Phase.
Christine Warman, RCVS Head of Education, said: "Since it is coming up to three years since we introduced the Code we thought that now is a good time to take stock of the proportion of veterinary surgeons that are fulfilling the requirement and how they are doing so.
"It is also a good time to remind members of the profession of the importance of CPD and that it is not just a tick-box exercise but vital for everyday practice. Engaging in CPD is a personal obligation for all veterinary surgeons and demonstrates to both the profession and public that they are continually advancing their capability and competence.
"This year we will be providing some guidance on what constitutes CPD and how to undertake it to those who are non-compliant. However, from 2015, we may also refer those who repeatedly fail to comply, or respond to requests to submit their records, to our Professional Conduct Department for further investigation."
Vets who have been selected to take part in the audit will have received letters in early November and will have until Monday 1 December to respond. They can do so by either allowing the RCVS to view their online Professional Development Record (PDR) profile or by submitting their paper CPD record by post or by sending the College a scanned copy by email.
For further advice and to submit a CPD record by email, contact cpd@rcvs.org.uk. Those who have not yet registered for the PDR can do so by visiting www.rcvs-pdr.org.uk
Axiom Veterinary Laboratories has launched SLIT - sublingual immunotherapy treatment - for allergies in cats, dogs and horses.
According to the company, sublingual immunotherapy has been shown to be safe and effective in humans for over 20 years and a recent study has shown it to be a beneficial alternative way of administering immunotherapy to cats, dogs and horses, proving particularly effective in treating animals that failed to respond to allergy shots.
Patients can convert from shots to drops with an initial treatment kit.
Martyn Carpenter, Director of Axiom Laboratories Ltd, said: "Each ACTT Allergy Drop prescription is a custom formulation containing the specific allergens that are causing the pet's discomfort. Allergy drops are prepared in a glycerin solution to provide antigen stability, and have a slightly sweet taste, which assists in palatability and ease of administration. This method greatly reduces irritation and the likelihood of anaphylactic shock and can be administered easily at home by the client, freeing up consult slots and removing the stress which accompanies a visit to the surgery for many pets. This can be a particularly suitable alternative for those clients on a restricted budget, for whom on-going consult and injecting fees can be prohibitive to compliance with immunotherapy treatment. "
For more information, contact Axiom's Diagnostic Support Team on 01626 355655
Protexin says Pro-Kolin Advanced contains beneficial micro-organisms, several prebiotic sources, an optimal level of a dual-source binding agent and soothing fibres to support gastrointestinal function.
The company also says that in a study involving 148 dogs, Pro-Kolin Advanced significantly improved clinical outcome compared to a placebo1.
Protexin Veterinary Director, James Kyffin, said: "Pro-Kolin Advanced represents an exciting development for Protexin Veterinary and fits in perfectly with our ethos to produce innovative, research-based products of the highest quality for pets.
"It is the first product of its kind to be supported by a randomised, controlled clinical trial that was undertaken in first opinion veterinary practices across the UK and Ireland.
"Not only are we pleased to be able to offer veterinary surgeons with an evidence-based option for the management of acute gastrointestinal disturbances, but also a very palatable formulation that was readily accepted by 92% of the dogs in the study."
Pro-Kolin Advanced is available in 15ml, 30ml and 60ml syringes for dogs and 15ml syringes for cats. The flavourings used in the product contain no proteins or common allergens so Pro-Kolin Advanced can be used in animals with known hypersensitivities.
Novartis Animal Health UK Ltd has announced the launch of CLiKZiN Pour On for sheep, a short meat withhold period (MWP) product that can be used throughout Spring and Summer for the prevention of blowfly strike in sheep and lambs.
CLiKZiN is a ready-to-use water-based product that protects sheep for eight weeks, and has a meat withhold period of seven days. The product is a line extension of CLiK which offers a longer period of protection at 16 weeks and has a longer withhold period of 40 days. Novartis says that used in conjunction with CLiK, CLiKZiN offers versatile protection throughout the year.
The launch of CLiKZiN comes at the same time that Vetrazin has been reformulated, resulting in a longer meat withhold period for sheep treated with the product.
Thomas Tiley MRCVS from Novartis Animal Health said: "Farmers need reliable protection from the repugnant threat of blowfly strike. CLiKZiN provides eight weeks blowfly prevention together with the trusted performance and safety record associated with CLiK. It also offers the greater flexibility of a seven day meat withhold.
"This makes CLiKZiN ideally suited for a variety of production schedules and stock including lambs for slaughter and pre-shearing ewes."
Blowfly strike can be devastating to sheep, causing severe impact on the welfare of the animal. Within days of a blowfly laying its eggs, clinically normal sheep can be afflicted with flesh eating maggots. This makes prompt and effective treatment critical.
National Sheep Association Chief Executive Peter Morris said: "Fly strike is a terrible burden to the sheep industry both in terms of the welfare of the sheep and economically.
"Having a product available that gives effective prevention against fly strike whilst at the same time having a withdrawal period which does not impinge on the ability of the sheep farmer to market lambs is very welcome. The sheep farmers' armoury against the every day afflictions which affect sheep has been significantly enhanced."
VetSurgeon is sad to report that Sam Duff, a much loved figure in the profession, died last weekend.
Sam qualified from Edinburgh in 1970, and was a partner in mixed practice in Fife until 2002. More recently, he was a director of Equitique Ltd, an equine reproduction referral practice.
Sam was an active member of BVA Council, and its Member Services Group. He served on SPVS Council from 1993-2002, and was re-elected in 2003. He had recently been elected as Secretary of the Scottish branch of the BVA.
A memorial service will be held at 2.30pm on Thursday 9th July in Younger Hall, St Andrews.
Allegations were reported both in The Times, and the Veterinary Record.
In its statement, the College said: "We know that the University of Edinburgh takes any such accusations extremely seriously and that its inquiry fully and robustly investigated the claims in 2019. This inquiry found no evidence of misconduct, a decision that was later upheld after an appeal.
The College recognised the massive impact that bullying can have on anyone who has been subject to it and acknowledged that the individual accounts published in the Veterinary Record were upsetting to read. However it also drew attention to the 'huge amount of stress that can be caused by ‘trial by media’, especially when an inquiry has concluded that there were no issues to be found'.
As to the role of the RCVS Junior Vice-President, the College pointed out that this is a matter for RCVS Council, as the postholder is elected by Council.
Professor Argyle will be making a statement to Council at its next meeting on 5th November, after which Councillors will be able to ask any questions they have, and then consider the matter.
Meanwhile, the College has asked the Vet Record whether any of the people who made the anonymous testimonials would like to supply any information directly.
Animal Friends is launching a pilot programme through which its customers will be able to check their pets' symptoms, get advice on treatment or find out if they need to visit a vet clinic on Joii.
Paul Hallett, co-founder of Vet-AI said: "Animal Friends is a perfect partner for Vet-AI, not only do we share common goals around animal welfare and the profession as a whole, but strategically we are both laser focused on the customer. In the coming few years we will support their customers by providing them with 24 hour expert-led care, at the click of a button. This will drive our business forward, helping us reach more pet owners and improve the care their pets receive."
Wes Pearson, Managing Director of Animal Friends said: "This partnership demonstrates our commitment to provide our pet parents with innovative options to ensure their pet receives the best care. Being able to access professional advice from the comfort of their own home and at a time that suits them can dramatically reduce stress for both the pet and the pet parent. We are excited to be working with Vet-AI and believe that the Joii app will bring expert knowledge and extra peace of mind to our customers."
Oh no, not another company talking about 'pet parents'. Is it just me, or is it not rather patronising?
Mr Wood faced three charges, all relating to allegations of misconduct over a laboratory test for an alpaca while he was working at a practice in South Oxfordshire.
The charges alleged that in September 2023, Mr Wood told the alpaca’s owner that it had tested positive for Johne’s disease when in fact, the animal had not been tested.
He then allegedly sent a letter confirming a positive test result for the test that had not taken place, and then created a false test result report in the name of a veterinary surgeon colleague and sent it to another colleague by email.
He later told the alpaca's owner that he had given her the wrong result by mistake and that the test result was actually negative.
Then in October 2023, he emailed the laboratory saying that a member of his practice’s administrative staff had written the false report.
In November he told the managing partner of his then employer on three occasions that he was investigating the false report in order to find out who sent it.
Finally, he sent a misleading and dishonest email to a veterinary surgeon colleague falsely indicating that a member of the practice’s staff had manufactured the false report, when that was not the case.
At the outset of the hearing Mr Wood admitted the facts of all the allegations against him.
Having found the facts proven, the Committee found that the charges amounted to serious professional misconduct, something which Mr Wood himself also admitted.
The Committee identified a number of aggravating factors in Mr Woods' conduct, including his lack of honesty, probity and integrity, the fact the conduct was premeditated, that it involved a breach of the client’s trust, the abuse of his professional position, the fact the conduct was sustained and repeated over a period of time, and that his conduct contravened advice given by the RCVS.
The mitigating factors included positive testimonials from professional former colleagues and client farmers, the fact that he had engaged in some remediation in order to avoid repeating the dishonest behaviour, and that he showed significant insight into his misconduct.
Dr Neil Slater MRCVS, chairing the Committee and speaking on its behalf, said: “The Committee recognised that the serious repeated dishonesty, which was to conceal wrongdoing, made the respondent’s misconduct particularly serious.
“It therefore gave consideration as to whether his conduct was fundamentally incompatible with being a veterinary surgeon and whether removal was the only appropriate and proportionate sanction in this case.
“The Committee considered that this was a particularly difficult case to reconcile, as, on the one hand the misconduct was so serious whereas on the other hand, the respondent had demonstrated significant insight; the risk of repetition was low; the evidence of his professional achievements was strong and the testimonials from client farmers and professional colleagues were impressive.”
He added: “The Committee considers that suspension is sufficient in the circumstances of this case to satisfy public confidence in the profession and to uphold proper professional standards of conduct and behaviour.
"The Committee therefore imposes a suspension of 18 months on the respondent.
"In determining this length, the Committee considered that this was the least period necessary in order to meet the significant public interest considerations in this case.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
The procedure was performed in Canada through an international collaboration between partners from Germany, Canada and the UK, who say that this was a case where the placement of the tumour made it impossible to operate without severely impacting the dog’s quality of life. The most suitable treatment was a total excision of the growth and reconstruction with an implant.
The implant was designed with medical CAD tools by German company, Voxelmed, using 3D imaging from the affected area. The dog's veterinary surgeon, Julius Liptak, contributed to the design to ensure it met specifications and allowing him to plan the procedure in advance.
UK company Renishaw then additively manufactured the patient specific implant (PSI) at the Additive Design In Surgical Solutions (ADEISS) Centre in London, Ontario, Canada.
Ed Littlewood, Marketing Manager at Renishaw’s Medical and Dental Products Division said: "Without the advancements in additive manufacturing technology, this dog would not have had such a long and happy future ahead of him.
"Prior to this case, many veterinary surgeons were unaware that the technology was available. Similar procedures are now being planned in Germany and further research is underway to see how animals can benefit from additively manufactured PSIs.
Jan Klasen, veterinary surgeon, 3D designer and CEO of Voxelmed said: "Without AM technology, it would have been almost impossible to reconstruct the dog’s maxilla after tumour removal, because the area was extremely complex in geometry. The implant had to have a similar shape and functionality as the dog’s existing bone structure.
"Using additive manufacturing to maintain the original shape and function of the oral and nasal cavity ensures a high quality of life for the dog, just as a naturally shaped skull and maxilla helps the dog to breathe and eat easily."
To read the full case study, visit http://www.renishaw.com/en/additive-manufacturing-in-veterinary-surgery-saving-a-well-loved-member-of-the-family--42950.
The College says the speed and accuracy of scans produced by the new scanner will revolutionise the treatment of animals at the Queen Mother Hospital for Animals (QMHA). It also reduces the need for animals to be anaesthetised before being scanned, with most patients now only requiring partial sedation.
The new scanner has been named the 'Otter Scanner' after a patient of the RVC whose owner was made a significant donation towards the RVC's charity, the Animal Care Trust, which funded the new machine.
Professor Dan Chan, Professor of Emergency and Critical Care Medicine and Medical Director of the QMHA at the RVC, said: "It is very uncommon that such an incredible leap in the care of animals can be achieved with a single innovation.
"Because of the vast improvement in speed and quality of the images produced by the ‘Otter Scanner’ our specialists are now able to obtain much more detailed images of various diseases affecting our patients so that the best possible treatment can be planned.
"At the RVC, one of our most important missions is to always improve the welfare and care of animals and this latest innovation is just another example of that commitment. We are forever grateful to all our supporters who have made this possible."
RCVS Council agreed, in principle, to the sale of Belgravia House and for the College and its London-based staff to move to different premises at its November meeting.
The sale of the building and the move will be overseen by the College’s Estate Strategy Project Board headed by former RCVS President Barry Johnson and including current and former RCVS Council members and RCVS staff.
The RCVS has been based at its current premises in 62-64 Horseferry Road for 25 years, but says it now needs more up-to-date and modern facilities to accommodate a projected increase in the number of staff.
The College says it has considered a number of alternatives, including expanding the current premises by adding or expanding floors. However, due to the fact that the building is in a conservation area, it has become clear that any such expansions would be unlikely to get planning permission from Westminster Council.
Lizzie Lockett, RCVS Chief Executive, said: "For a number of years it has become apparent that it is fast approaching the time at which our current premises will no longer be fit for purpose due to an increase in the number of RCVS staff – something that is projected to continue in the future – the ongoing need to use the building for Disciplinary Hearings, which take over the lion’s share of available meeting space, and the need for better and more modern facilities.
"Even putting our need for increased space on one side, Belgravia House requires major refurbishment in key areas such as air-conditioning and lifts, which would require staff to vacate the premises for up to 18 months, which would be costly and disruptive.
"We are therefore pleased that Council has recognised the need for the College to move somewhere that better reflects our needs and, over the coming months, we will be exploring a number of different options for new premises.
"In parallel to this we have put out an invitation to tender for agents to manage the sale of the building. The plan is for the arrangement to include lease-back so that we have time to find a suitable premises and enabling us to act quickly when we do."
Any organisations that are interested in putting forward a tender to manage the sale of the building should contact Corrie McCann, RCVS Director of Operations, on 020 7202 0724. Responses to tender are required by 30 November 2018.
Photo: Copyright Google 2018
Vetoquinol is launching Cimalgex, a new NSAID for dogs this month.
Cimalgex (cimicoxib) is a new second generation COX-2 inhibitor which can be used for the treatment of pain and inflammation due to osteoarthritis and the management of peri-operative pain associated with orthopaedic and soft tissue surgery, for which it can be given two hours before surgery and continued for 3-7 days post surgery.
Vetoquinol says that an important consideration in treating dogs with osteoarthritis, many of which are geriatric, is that there are no contraindications to using Cimalgex in patients with mild to moderate renal impairment.
According to the company, field trials showed that over 90 per cent of per owners and vets identified that animals experienced excellent analgesia post operatively*.
Available in a chewable, splitable tablet, Cimalgex can be given with or without food.
Vetoquinol says that the excellent tolerability, efficacy profile and ease of use of Cimalgex means that veterinary patients could benefit from pain relief in situations where clinicians are worried about the risks versus the benefits of prescribing a NSAID for pain management.
Further information about assessing pain and decision making when it comes to prescribing NSAIDs, will be presented in a free webinar on 19th October at 8.30pm. To register go to www.thewebinarvet.com/vetoquinol and enter code CIM1.
Reference*E. Grandemange: Field evaluation of the efficacy and the safety of cimicoxib in the relief of peri-operative pain in dogs; 2008, study number n°3008C2F1
Budding veterinary impresario Noel Fitzpatrick has announced the dates for the inaugural VET Festival, an outdoor summer event for the profession which will combine world-class CPD with family entertainment and an evening rock concert headlined by Mike Rutherford of Genesis fame.
The VET Festival, sponsored by NVSL and Natural Instinct, will take place in the grounds of the University of Surrey on Saturday 5th and Sunday 6th September 2015.
In a complete departure from the way CPD is usually delivered, lectures will take place in a 1000-seat main theatre marquee in the middle of the university campus, surrounded by smaller breakout tents, exhibitors, family entertainment and 'street food'.
Noel said: "The simple goal of The VET Festival is to provide education which is both cutting-edge and relevant to the day-to-day clinical work of vets, vet nurses and veterinary professionals in companion animal practice. But we also seek to make education fun - like going to a movie - something you can treasure, enjoy and then readily employ in clinical practice.
"There are four lecture strands: orthopaedics, oncology and soft tissue surgery, neurology, and veterinary nursing. Ten education themes will be delivered by world-class lecturers with significant experience in clinical veterinary practice. We will present this education on an innovative platform combining a fun festival atmosphere with dynamic delivery. We aim to provide real value for money, with tickets priced very affordably for a packed educational program which can also form part of the 35 CPD points needed throughout the year."
In addition to Noel himself, speakers at the event (pictured below), include: Will Eward (Assistant Professor of Orthopaedic Surgery Duke University), Nick Bacon (Head of Surgical Oncology, Fitzpatrick Referrals), Julia Tomlinson (Diplomate, American College of Veterinary Sports Medicine and Rehabilitation Twin Cities Animal Rehabilitation and Sports Medicine Clinic), Duncan Lascelles (Professor of Surgery and Pain Management at North Carolina State University College of Veterinary Medicine), Ian G Holsworth (Director VetSurg Small Animal Hospital, Ventura, California), Nick Jeffrey (Professor, Neurology and Neurosurgery College of Veterinary Medicine, Iowa State University), Laurent Findji (Senior Surgeon Soft Tissue and Oncology, Fitzpatrick Referrals) and Jolle Kirpensteijn (Chief Professional Relation Officer, Hill's Pet Nutrition).
And if that wasn't enough, there'll be an evening concert on the Saturday headlined by Mike and the Mechanics. The ONE LIVE concert is being held to promote "One Life One Medicine": the belief that we all only have one life and that there should be a symbiosis of effort to move animal and human medicine forward together. It's in support of The Humanimal Trust, the UK's first charity to further the principles of One Medicine and with the aim of progressing clinically relevant healthcare initiatives for both animals and humans at the same time.
Mike Rutherford said: "I am a huge supporter of 'One Life - One Medicine' - combining animal and human health is an important way forward and I'm looking forward to playing at the Festival, as are the rest of the Mechanics! It will be a fantastic week end - not to be missed!"
As a media partner for the event, VetSurgeon.org will be offering members a special discount, more details to be announced in due course. Publishing Editor Arlo Guthrie said: "Sounds like it should be a lot of fun, and could be a great opportunity for some of our members to meet up and have a pint or two."
All VetSurgeon members can have a 10% discount on the ticket price, by visiting the following link and entering the code VFVSURGEON10
http://www.eventbrite.co.uk/e/the-vet-festival-2015-tickets-16256763417?aff=VFVSURGEON10
For more information about the VET Festival visit: www.vetfestival.co.uk
Running throughout October, the campaign is designed to raise awareness among dog owners of how Adaptil Calm can help dogs cope during the fireworks and Christmas party season.
The advertising campaign will target 3.3 million pet owners and it will air on over 60 channels including C4 channels (Channel 4, E4, More4, Film4, Drama, Good Food, Really, W and Home), Sky channels, ITV2 and ITVBe.
Abigail King, behaviour product manager at Ceva Animal Health, said: "The fireworks and party season can be an extremely upsetting time of the year for the nation’s pets.
"By highlighting the benefits of Adaptil at this key time of the year we hope to ensure that dogs are better prepared for the challenges of fireworks and loud noises."
Ceva says the TV advertising campaign will be supported by a digital campaign for both Adaptil and Feliway.
To watch the Adaptil TV advertisement visit https://www.adaptil.com/uk/Success-Stories/Finley.
Miss Herdman faced three charges.
The first was that she indicated to a friend that she would supply diazepam and/or tramadol for use by their husband.
The second was that she supplied diazepam and/or tramadol and/or gabapentin.
The third was that she gave advice on the dosages of diazepam and/or tramadol and/or gabapentin.
Miss Herdman was not present at the hearing and was unrepresented, but the Committee determined that it was appropriate to proceed in her absence as she had been notified, was aware that the hearing was taking place and her absence was voluntary.
However, Miss Herdman had been in contact to indicate her pleas to the charges.
She admitted the intention to supply diazepam and/or tramadol and that she had provided advice on the dosages.
She also admitted that she had supplied diazepam but strongly denied that she had supplied tramadol and/or gabapentin.
Taking all the evidence into account (including messages sent by Miss Herdman and her admissions), the Committee found proven the charges in relation to the intent to supply and the advice on dosages.
The Committee also found proven the charge in relation to the supply of diazepam, but found not proved the charge relating to the supply of tramadol and gabapentin for several reasons, including the fact that the messages sent by Miss Herdman did not point unequivocally to her actually suppling each of the drugs to which she referred.
There was no suggestion that the diazepam was stolen from her place of work.
The Committee found that Miss Herdman’s actions had breached paragraphs 1.5 and 6.5 of the Code of Professional Conduct for Veterinary Nurses.
The committee judged that there were a number of aggravating features of Miss Herdman’s conduct, including that she was not qualified or authorised to prescribe medication to animals, let alone to human beings and that providing a controlled drug to a person who was already taking various painkilling medications was reckless.
The Committee also felt that a reasonable and informed member of the public would be very concerned to learn that a veterinary nurse had supplied a controlled drug to a friend for their personal use.
Regarding the sanction for Miss Herdman, Paul Morris, chairing the Veterinary Nursing Disciplinary Committee and speaking on its behalf, said: “Drawing all the material together, and considering the matter as a whole, the Committee had to impose a proportionate sanction for an isolated incident of serious professional misconduct which arose out of a misguided attempt to help a friend.
"The conduct in question was entirely out of keeping with Miss Herdman’s usual practice and there is no real risk that it will be repeated.
"However, this case was much too serious to take no further action and no useful purpose would be served by postponing a sanction.
“The Committee considered that a warning or reprimand would not be sufficient to satisfy the public interest as veterinary nurses are trusted by the public to deal with medication responsibly and failure to do constitutes a severe breach of trust.
“The Committee therefore considered a period of suspension sufficient to meet the public interest in maintaining the reputation of the profession and declaring and upholding proper standards of conduct for members of the profession.
“The Committee also considered whether a removal order would be appropriate but concluded it would be disproportionate and that such a step would remove from the profession an experienced, competent and valuable veterinary nurse for no discernible benefit.
“It was decided that Miss Herdman’s registration be suspended for a period of three months – a period which is sufficient to mark the gravity of the misconduct while taking into account the circumstances in which it arose.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings/
All practices are eligible to register and no FCA authorisation is needed.
Carefree Credit says it will also process applications to make practice administration hassle free.
Mike Aldred, Director at Carefree Credit, said: "With the deepening cost of living crisis, owning a pet has never been more expensive for many pet owners and having these longer terms available will really help their pets get the treatment they need."
To register your practice with Carefree Credit, email office@carefreecredit.co.uk or call 0345 313 0177.
https://www.carefreecredit.co.uk
The survey, which received 2445 responses from BVA members, found that 16% of vets and vet students have personally experienced discrimination within a veterinary workplace or learning environment in the past twelve months, while 20% had witnessed discrimination.
Senior colleagues were most commonly responsible for the discrimination (47% of incidents), with discrimination from clients accounting for 35% of incidents.
Sex discrimination was the most common type reported (44% of incidents) and was particularly prevalent in academic settings and in production animal, equine, and mixed practices.
Race discrimination was the next most commonly reported (27% of incidents).
Respondents also gave details of discrimination in relation to other protected characteristics, including age, sexuality, disability and gender reassignment.
Younger vets were more likely than older vets to have personally experienced discrimination in the past year (27% of those under 35 had experienced discrimination).
Female vets were more than twice as likely to have experienced discrimination than their male colleagues (19% and 8% respectively).
The incidence of discrimination was higher amongst vets from a range of minority ethnic backgrounds. Those who described their sexual orientation as bi, gay or lesbian were twice as likely to have personally experienced discrimination in the past year.
Despite the high incidence of discrimination reported, responses to the same survey showed that only 56% of the profession feel concerned about discrimination.
British Veterinary Association Junior Vice President Daniella Dos Santos (pictured right) said: "This is the first time anyone has collected such a significant body of evidence on this issue and the results are truly shocking. It is completely unacceptable that so many members of the veterinary team are subject to discrimination not just from clients but from members of our own profession.
"Worryingly, it seems that the scale of the issue will come as a surprise to many members of our profession and so it is vital that we all join the conversation and reflect on what role we can play to improve equality and inclusion. The veterinary team must become a safe and supportive environment for everyone. We cannot accept anything less for ourselves, for our colleagues and for our profession."
Only 12% of respondents were satisfied with how their incident had been dealt, rising to 23% among those who felt able to report. Daniella said: "Many of the experiences documented in our report are shocking and distressing and this distress is often compounded by what comes next. It was very saddening to hear that so many people have felt unable to report their experiences or that their reports were handled badly by those who received them.
"Experiencing discrimination can be very traumatic, without the ‘double-whammy’ of having your complaint dismissed or mishandled by managers or senior staff. We need to make sure everyone who experiences discrimination is able to get the outcome they deserve.
"Through the discrimination questionnaire we heard many distressing stories from vets, students, vet nurses and other colleagues. We are incredibly grateful to them for sharing these with us so that we can raise awareness of what’s happening in our veterinary workplaces."
To raise awareness of the scale of the issue, the BVA is inviting all members of the veterinary team to join a "Big Conversation on equality and inclusion in the veterinary professions", starting with the release of its report on the current situation on discrimination, which can be downloaded here, then inviting everyone to join online engagement sessions through social media and BVA members to feed in views via their regional representatives ahead of Council on 24 July.
Chanelle has announced the launch of Ketamidor 100 mg/ml Solution for Injection (ketamine), licensed for use in cats, dogs, horses, cattle and swine in the UK and Ireland.
The company says the new product provides a versatile addition to anaesthetic regimes. It can be used in combination with other widely-used anaesthetics and sedatives. Chanelle says it also has analgesic properties that make it particularly beneficial to include in anaesthetic protocols when carrying out painful surgical procedures.
Ketamidor 100mg/ml Solution for Injection has a zero day withdrawal period for milk and meat when used in cattle and pigs, allowing high welfare standards to be maintained without compromising economic returns.
According to Chanelle, ketamine is now experiencing a resurgence of interest as its analgesic properties and minimal impact on spontaneous respiration become increasingly appreciated.1
Angela Wilkin, Chanelle UK's Sales and Marketing Manager said: "Ketamidor makes a great addition to our portfolio of pain management products. Our territory managers are looking forward to speaking to those vets who are already accustomed to using ketamine and those that may be considering adding it to their current protocols."
The publishers say that with a global donkey population estimated at around 46 million, it’s imperative for the veterinary profession to stay well-informed about the unique biology and disease susceptibility of this species.
The virtual collection addresses the previous shortfall of pathophysiological information, with articles on pharmacology, diagnostics, disease prevalence and management practices relating to donkeys as working, companion and production animals.
Preventative healthcare is addressed with a study of a companion population of donkeys in the UK and clinicians are encouraged to focus on client education, promotion of vaccination, regular dental care, strategic parasite control programmes and weight management.
Several papers address decision-making around treatment options, emphasising the need for a good understanding of the pharmacology of the available therapeutic agents in relation to donkeys and the pathophysiology of the diseases, as well as the value of pain assessment and control.
Another important aspect of disease detection and management is the availability of accurate diagnostics. Several papers address aspects of diagnostic testing, with emphasis on the caution that must be taken when extrapolating from horses because of the minimal data relating specifically to donkeys.
Donkeys are often described as silent carriers of, or as being more resistant to, infectious agents. Two articles demonstrate that they can in fact develop severe clinical signs when exposed to certain known equine pathogens, raising the importance of surveillance, accurate diagnosis, outbreak management, disease control and clear communication and education.
Less common conditions in donkeys as well as awareness of zoonotic risk are addressed within the collection, emphasising the value of owner-driven reporting as part of a disease surveillance and control programme to inform decision making on relevant interventions.
Professor Celia Marr, Editor of the EVJ, said: “This impressive collection shines a spotlight on the important advances that have been made to donkey medicine and welfare and helps us to identify the research gaps yet to be filled
“By sharing this work, we aim to improve disease prevention and enhance the welfare of donkeys around the world as well as highlight the continued importance of owner education and improve the public perception of this enduring species.”
The virtual issue can be found here: https://beva.onlinelibrary.wiley.com/doi/toc/10.1001/(ISSN)2042-3306.donkey-medicine-welfare.vi
According to the survey, 64% of veterinary surgeons now see Brexit as more of a threat than an opportunity for the UK veterinary profession, compared to just half in autumn 2016. Conversely, the number that see Brexit as being more of an opportunity has dropped from 18% to 14% over the same period.
Vets working in academia and industry were the most gloomy: 69% of vets in academia and 58% of vets in industry see Brexit as more of a threat to their own area of work than an opportunity.
The biggest impact appears to have been on veterinary recruitment, with 53% saying Brexit has made it harder to recruit veterinary surgeons, compared to only 18% in 2016. By comparison, only 11% said it has become harder to recruit veterinary nurses.
51% also now consider Brexit as a threat to animal welfare, compared to 43% in 2016.
BVA President Simon Doherty (pictured right, looking decidedly chipper despite it all) said: "As the UK Government ramps up its planning for a no-deal scenario, it’s clear that the veterinary profession is becoming increasingly concerned about the potential impact of Brexit.
"Top of vets’ list of concerns is significant veterinary workforce shortages across critical areas of animal welfare and public health. Veterinary concerns around animal welfare have also increased as the Government continues to stall on introducing new legislation to enshrine animal sentience in UK law before March.
"From pet passports and food safety, to disease surveillance and trade certification, there is no area of veterinary work that is not touched by Brexit. So, we can fully understand why our members are worried about the future. BVA will continue to raise these important veterinary issues with policymakers to ensure the profession is considered as Brexit discussions continue."
The BVA briefings on “Brexit and the veterinary profession” and “No deal Brexit and the veterinary profession” set out all of the issues of interest in more detail.
Animalcare has released further information about Vitofyllin (propentofylline), its new CNS stimulant for dogs.
According to the company, Vitofyllin helps restore vitality and willingness to exercise, especially in the senior dog, by improving peripheral and cerebral vascular blood circulation. It is indicated to help improve dullness, lethargy and overall demeanour in dogs. In addition it has a bronchodilatory activity equivalent to amilophylline (a salt of theophylline)
Animalcare says that with dogs living longer, age-related problems are on the increase. The company highlights the example of Cognitive Dysfunction Syndrome (CDS), a neurodegenerative disease that affects older dogs. CDS is characterised by various pathological processes with signs that include disorientation, changing interaction with people or other pets, sleep-wake cycle alterations, soiling in the house and decreased activity levels.
The company says these subtle behavioural changes are unlikely to be picked up at a routine annual check. Indeed, in one study 75% of owners of dogs aged over 7 reported at least one behavioural sign consistent with CDS, however only 12% reported their concerns to a vet.2
Vitofyllin is available in 50mg and 100mg strengths in blister packs containing 56 tablets. Presented as 'easy to administer' four-way split cross-snap-tabs which can be divided into halves or quarters to enable more accurate dosing to be achieved whatever the weight of animal, even down to 2.5kg bodyweight.
Vitofyllin is POM-V licensed and has a 3 year shelf-life. Waiting room posters and client leaflets are available to support recognition of behavioural signs by clients and practice staff.
Further iinformation, and details about a special launch offer are available from local Animalcare representatives.